Hepatocytes direct the formation of a pro-metastatic niche in the liver
Jae W Lee, Meredith L Stone, Paige M Porrett, Stacy K Thomas, Chad A Komar, Joey H Li, Devora Delman, Kathleen Graham, Whitney L Gladney, Xia Hua, Taylor A Black, Austin L Chien, Krishna S Majmundar, Jeffrey C Thompson, Stephanie S Yee, Mark H O'Hara, Charu Aggarwal, Dong Xin, Abraham Shaked, Mingming Gao, Dexi Liu, Mitesh J Borad, Ramesh K Ramanathan, Erica L Carpenter, Ailing Ji, Maria C de Beer, Frederick C de Beer, Nancy R Webb, Gregory L Beatty, Jae W Lee, Meredith L Stone, Paige M Porrett, Stacy K Thomas, Chad A Komar, Joey H Li, Devora Delman, Kathleen Graham, Whitney L Gladney, Xia Hua, Taylor A Black, Austin L Chien, Krishna S Majmundar, Jeffrey C Thompson, Stephanie S Yee, Mark H O'Hara, Charu Aggarwal, Dong Xin, Abraham Shaked, Mingming Gao, Dexi Liu, Mitesh J Borad, Ramesh K Ramanathan, Erica L Carpenter, Ailing Ji, Maria C de Beer, Frederick C de Beer, Nancy R Webb, Gregory L Beatty
Abstract
The liver is the most common site of metastatic disease1. Although this metastatic tropism may reflect the mechanical trapping of circulating tumour cells, liver metastasis is also dependent, at least in part, on the formation of a 'pro-metastatic' niche that supports the spread of tumour cells to the liver2,3. The mechanisms that direct the formation of this niche are poorly understood. Here we show that hepatocytes coordinate myeloid cell accumulation and fibrosis within the liver and, in doing so, increase the susceptibility of the liver to metastatic seeding and outgrowth. During early pancreatic tumorigenesis in mice, hepatocytes show activation of signal transducer and activator of transcription 3 (STAT3) signalling and increased production of serum amyloid A1 and A2 (referred to collectively as SAA). Overexpression of SAA by hepatocytes also occurs in patients with pancreatic and colorectal cancers that have metastasized to the liver, and many patients with locally advanced and metastatic disease show increases in circulating SAA. Activation of STAT3 in hepatocytes and the subsequent production of SAA depend on the release of interleukin 6 (IL-6) into the circulation by non-malignant cells. Genetic ablation or blockade of components of IL-6-STAT3-SAA signalling prevents the establishment of a pro-metastatic niche and inhibits liver metastasis. Our data identify an intercellular network underpinned by hepatocytes that forms the basis of a pro-metastatic niche in the liver, and identify new therapeutic targets.
Conflict of interest statement
The authors have no competing financial interests.
Figures
References
- Hidalgo M Pancreatic cancer. N. Engl. J. Med 362, 1605–1617 (2010).
- Becker A et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30, 836–848 (2016).
- Sceneay J, Smyth MJ & Möller A The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 32, 449–464 (2013).
- Hingorani SR et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469–483 (2005).
- Lee JW, Komar CA, Bengsch F, Graham K & Beatty GL Genetically engineered mouse models of pancreatic cancer: the KPC model (LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre), its variants, and their application in immuno-oncology drug discovery. Curr. Protoc. Pharmacol 73, 14.39.1–14.39.20 (2016).
- Rhim AD et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349–361 (2012).
- Grünwald B et al. Pancreatic pre-malignant lesions secrete TIMP1, which activates hepatic stellate cells via CD63 signaling to create a pre-metastatic niche in the liver. Gastroenterology 151, 1011–1024 (2016).
- Seubert B et al. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology 61, 238–248 (2015).
- Hoshino A et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329–335 (2015).
- Costa-Silva B et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol 17, 816–826 (2015).
- Kowanetz M et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. USA 107, 21248–21255 (2010).
- Hiratsuka S et al. The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol 10, 1349–1355 (2008).
- Hiratsuka S, Watanabe A, Aburatani H & Maru Y Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol 8, 1369–1375 (2006).
- Schmidt-Arras D & Rose-John S IL-6 pathway in the liver: From physiopathology to therapy. J. Hepatol 64, 1403–1415 (2016).
- Long KB et al. IL6 receptor blockade enhances chemotherapy efficacy in pancreatic ductal adenocarcinoma. Mol. Cancer Ther 16, 1898–1908 (2017).
- Lesina M et al. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19, 456–469 (2011).
- Fukuda A et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell 19, 441–455 (2011).
- Corcoran RB et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res. 71, 5020–5029 (2011).
- Eckhardt ER et al. Intestinal epithelial serum amyloid A modulates bacterial growth in vitro and pro-inflammatory responses in mouse experimental colitis. BMC Gastroenterol. 10, 1–9 (2010).
- Urieli-Shoval S, Linke RP & Matzner Y Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol 7, 64–69 (2000).
- Chan-Seng-Yue M et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538, 1–20 (2016).
- Yachida S et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
- Reichert M et al. Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer. Dev. Cell 45, 696–711 (2018).
- de Beer MC et al. Impact of serum amyloid A on high density lipoprotein composition and levels. J. Lipid Res 51, 3117–3125 (2010).
- Liang WS et al. Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing. PLoS ONE 7, 1–20 (2012).
- Long KB et al. IFNγ and CCL2 cooperate to redirect tumor-infiltrating monocytes to degrade fibrosis and enhance chemotherapy efficacy in pancreatic carcinoma. Cancer Disc. 6, 400–413 (2016).
- Soares KC et al. A preclinical murine model of hepatic metastases. J. Vis. Exp 91, 1–10 (2014).
- Ma Y, Gao M, Sun H & Liu D Interleukin-6 gene transfer reverses body weight gain and fatty liver in obese mice. Biochim. Biophys. Acta 1852, 1001–1011 (2015).
- Tseng W, Leong X & Engleman E Orthotopic mouse model of colorectal cancer. J. Vis. Exp 10, 1–4 (2007).
- Klaas M et al. The alterations in the extracellular matrix composition guide the repair of damaged liver tissue. Sci. Rep 6, 1–12 (2016).
- Webb NR et al. Deficiency of endogenous acute-phase serum amyloid A protects apoE−/− mice from angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol 35, 1156–1165 (2015).
- Sun Y et al. Sudan black B reduces autofluorescence in murine renal tissue. Arch. Pathol. Lab. Med 135, 1335–1342 (2011).
- Kalbasi A et al. Tumor-derived CCL2 mediates resistance to radiotherapy in pancreatic ductal adenocarcinoma. Clin. Cancer Res 23, 137–148 (2017).
- Bindea G et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091–1093 (2009).
- Bindea G, Galon J & Mlecnik B CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data. Bioinformatics 29, 661–663 (2013).
- Shannon P et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
- The Gene Ontology Consortium. Expansion of the gene ontology knowledgebase and resources. Nucleic Acids Res. 45, D331–D338 (2017).
- Ashburner M et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet 25, 25–29 (2000).
- Subramanian A et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
Source: PubMed